Spots Global Cancer Trial Database for larynx cancer
Every month we try and update this database with for larynx cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Clinical Feasibility of New Tracheoesophageal Puncture Set | NCT01045057 | Larynx Cancer | Puncture Set an... | 18 Years - | Atos Medical AB | |
| Evaluations of Alcohol Warning Labels | NCT06129487 | Oral Cancer Esophageal Canc... Larynx Cancer Alcohol Drinkin... | Narrative picto... Non-narrative p... | 21 Years - | University of Connecticut | |
| Pembrolizumab in Combination With CRT for LA-SCCHN | NCT02586207 | Head and Neck C... Squamous Cell C... Oral Cavity Can... Oropharynx Canc... Hypopharynx Can... Larynx Cancer Laryngeal Cance... | pembrolizumab (... Cisplatin Radiation | 18 Years - | Sanford Health | |
| Phonatory Movement of the Pharyngoesophageal Mucosa in Laryngectomy Patients | NCT05561920 | Larynx Cancer Laryngectomy; S... | High - speed vi... Acoustic voice ... Quality of life... | 18 Years - 90 Years | Osijek University Hospital | |
| Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer | NCT06039631 | Larynx Cancer Hypopharyngeal ... | Surgery Radiation Toripalimab | 18 Years - 75 Years | Fudan University | |
| Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct Laryngoscopy | NCT03653039 | Oral Neoplasm Pharynx Cancer Larynx Cancer | Tritube Standard enditr... | 18 Years - | Rigshospitalet, Denmark | |
| Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation | NCT00169247 | Larynx Cancer Hypopharynx Can... | cetuximab Cisplatin Radiotherapy 70... | 18 Years - 75 Years | Groupe Oncologie Radiotherapie Tete et Cou | |
| Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | NCT03602079 | HER2-positive B... HER2 Gene Mutat... HER-2 Gene Ampl... HER2 Positive G... Salivary Gland ... Salivary Gland ... Salivary Gland ... Salivary Gland ... Lung Cancer Colo-rectal Can... Rare Diseases Solid Tumor Recurrent Gastr... Recurrent Colon... Recurrent Breas... Head and Neck C... Head and Neck C... Bladder Cancer Cervical Cancer Liver Cancer Bile Duct Cance... Urologic Cancer Pancreatic Canc... Prostate Cancer Recurrent Prost... Rectal Cancer Recurrent Ovari... Recurrent Renal... Rectal Cancer S... Rectal Cancer S... Rectal Cancer S... Skin Cancer Mouth Cancer Lip Cancer Stag... Tongue Cancer Breast Neoplasm... Larynx Cancer Tonsil Cancer Palate Cancer Mucoepidermoid ... Primary Periton... Mucinous Adenoc... Mucinous Breast... Cholangiocarcin... | A166 | 18 Years - | Klus Pharma Inc. | |
| Breath Testing in Early and Late Larynx Cancer | NCT01700647 | Larynx Cancer | Breath test- sa... Laryngoscopy an... | - | Royal Brisbane and Women's Hospital | |
| Evaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total PharyngoLaryngectomy | NCT05497947 | Pharyngeal Canc... Swallowing Diso... Larynx Cancer | 18 Years - | Centre Hospitalier de Valence | ||
| Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma | NCT00169182 | Larynx Cancer Hypopharynx Can... | DOCETAXEL Cisplatin 5-Fluoro-3-Pyri... | 18 Years - 75 Years | Groupe Oncologie Radiotherapie Tete et Cou | |
| Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy | NCT05337631 | HNSCC Oral Cavity Can... Oropharynx Canc... Hypopharynx Can... Larynx Cancer | 65 Years - | University Hospital Freiburg | ||
| The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors | NCT05798780 | Oral Cavity Can... Oropharynx Canc... Hypopharynx Can... Larynx Cancer | ENHANCE Interve... ENHANCE Interve... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer | NCT04057209 | Glottis Tumor Larynx Cancer | Single Vocal Co... Arm A: Transora... | 18 Years - | Insel Gruppe AG, University Hospital Bern | |
| Evaluations of Alcohol Warning Labels | NCT06129487 | Oral Cancer Esophageal Canc... Larynx Cancer Alcohol Drinkin... | Narrative picto... Non-narrative p... | 21 Years - | University of Connecticut | |
| GI Organ Tracking Via Balloon Applicators | NCT05471401 | Esophageal Canc... Kidney Cancer Larynx Cancer Liver Cancer Lung Cancer Digestive Organ... Intrathoracic--... Respiratory Org... Pancreas Cancer Small Intestine... Stomach Cancer Colon Cancer Rectal Cancer | Balloon-tipped ... | 18 Years - | Washington University School of Medicine | |
| Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma | NCT03174275 | Carcinoma, Squa... Oral Cancer Oropharynx Canc... Larynx Cancer Lip Cancer Esophageal Canc... | Durvalumab Carboplatin Nab-paclitaxel Cisplatin Surgical resect... IMRT | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer | NCT01984502 | Early-stage Glo... | CyberKnife Acce... | 18 Years - 99 Years | University of Texas Southwestern Medical Center | |
| Adaptive Radiotherapy for Head and Neck Cancer | NCT03096808 | Head and Neck C... Paranasal Sinus... Oropharynx Canc... Oral Cavity Can... Nasopharynx Can... Larynx Cancer Hypopharynx Can... | Adaptive Radiot... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis | NCT00661570 | Total Laryngect... | Provox Vega voi... | - | Atos Medical AB | |
| Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC | NCT00162708 | Oropharynx Canc... Oral Cancer Hypopharynx Can... Larynx Cancer | Radiotherapy 62... Radiotherapy 62... CDDP, 5 Fu | 40 Years - 75 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| Evaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients. | NCT03292341 | Larynx Cancer | Interviews Treatmentchoice... Questionnaires Interviews with... | 18 Years - | Maastricht Radiation Oncology | |
| Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer | NCT00080028 | Head and Neck C... Oropharynx Canc... Larynx Cancer Hypopharynx Can... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population | NCT00359645 | Pharynx Cancer Larynx Cancer Oral Cavity Can... Oesophageal Can... | Screening by he... | 40 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers | NCT04892875 | Head and Neck C... Squamous Cell C... Oral Cavity Squ... Oral Cavity Can... Oropharynx Canc... Oropharynx Squa... Larynx Cancer Pharynx Cancer Hypopharynx Can... Hypopharynx Squ... | Zimberelimab Etrumadenant Cisplatin Radiation | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| WEE1 Inhibitor With Cisplatin and Radiotherapy: A Trial in Head and Neck Cancer | NCT03028766 | Hypopharynx Squ... Oral Cavity Squ... Larynx Cancer | AZD1775 Cisplatin Radiotherapy | 18 Years - 70 Years | University of Birmingham | |
| Cell-free Tumor DNA in Head and Neck Cancer Patients | NCT03942380 | Head and Neck C... Head and Neck N... Head and Neck S... Oropharynx Canc... Oropharynx Neop... Oropharynx Carc... Oral Cavity Can... Oral Cancer Oral Neoplasm Larynx Cancer Larynx Carcinom... Larynx Neoplasm Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Neo... Hypopharynx Can... Hypopharynx Neo... Hypopharynx Car... Sinonasal Carci... Thyroid Carcino... Thyroid Cancer Thyroid Neoplas... Salivary Gland ... Salivary Gland ... Salivary Gland ... Sinonasal Cance... Sinonasal Neopl... | Liquid biopsy | 18 Years - | Rigshospitalet, Denmark | |
| Transoral Laser Surgery and Radiotheraphy for Early Stage Laryngeal Squamous Cell Cancer | NCT04778306 | Larynx Cancer | Transoral Laser... | 33 Years - 83 Years | Saglik Bilimleri Universitesi | |
| Quality of Life and Voice Perception in Patients Laryngoctomized Phonatory Wearers | NCT06086119 | Quality of Life Larynx Cancer | to assess the v... | 18 Years - | Regina Elena Cancer Institute | |
| Multi-Site Trial of Navigation vs Treatment as Usual for Delays in Starting Adjuvant Therapy | NCT05793151 | Head and Neck C... Head and Neck S... Oropharynx Canc... Oral Cavity Can... Larynx Cancer | ENDURE | 18 Years - | Medical University of South Carolina | |
| Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma | NCT03082534 | HNSCC Lip SCC Oral Cavity Can... Oropharynx Canc... Larynx Cancer Hypopharynx Can... Nasopharynx Can... Sinonasal Carci... Cutaneous Squam... Head and Neck N... Head and Neck C... Head and Neck S... | Pembrolizumab, ... | 18 Years - | University of California, San Diego | |
| CONFIRM: Magnetic Resonance Guided Radiation Therapy | NCT04368702 | Gastric Cancer Invasive Breast... in Situ Breast ... Mantle Cell Lym... Larynx Cancer Bladder Cancer | Viewray MRIdian... | 18 Years - | Dana-Farber Cancer Institute | |
| Immunological Function After Radiation With Either Proton or Photon Therapy | NCT06016699 | HNSCC Head and Neck C... Oropharynx Canc... Hypopharynx Can... Larynx Cancer | blood draws | 18 Years - | University Medical Center Groningen | |
| A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers | NCT04892875 | Head and Neck C... Squamous Cell C... Oral Cavity Squ... Oral Cavity Can... Oropharynx Canc... Oropharynx Squa... Larynx Cancer Pharynx Cancer Hypopharynx Can... Hypopharynx Squ... | Zimberelimab Etrumadenant Cisplatin Radiation | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| A Pilot Study of Acupuncture Treatment for Dysphagia | NCT00797732 | Carcinomas, Squ... Dysphagia | Acupuncture | 18 Years - | Dana-Farber Cancer Institute | |
| Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC | NCT00158652 | Oral Cancer Oropharynx Canc... Hypopharynx Can... Larynx Cancer | Conventional ra... middle accelera... very accelerate... 5FU, Paraplatin | 20 Years - 75 Years | Groupe Oncologie Radiotherapie Tete et Cou | |
| GI Organ Tracking Via Balloon Applicators | NCT05471401 | Esophageal Canc... Kidney Cancer Larynx Cancer Liver Cancer Lung Cancer Digestive Organ... Intrathoracic--... Respiratory Org... Pancreas Cancer Small Intestine... Stomach Cancer Colon Cancer Rectal Cancer | Balloon-tipped ... | 18 Years - | Washington University School of Medicine | |
| The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors | NCT05798780 | Oral Cavity Can... Oropharynx Canc... Hypopharynx Can... Larynx Cancer | ENHANCE Interve... ENHANCE Interve... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer | NCT03759431 | Cancer Neck Larynx Cancer Glottis Tumor | Vocal-cord Radi... Complete Larynx... | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| An Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma | NCT05217147 | Larynx Cancer Larynx Carcinom... | Obtaining blood... | - | Hacettepe University | |
| Bilateral Elective Neck Dissection in Salvage Total Laryngectomy | NCT05746780 | Neck Cancer Larynx Larynx Cancer Neck | Elective bilate... | 18 Years - 90 Years | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| An Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma | NCT05217147 | Larynx Cancer Larynx Carcinom... | Obtaining blood... | - | Hacettepe University | |
| A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers | NCT04892875 | Head and Neck C... Squamous Cell C... Oral Cavity Squ... Oral Cavity Can... Oropharynx Canc... Oropharynx Squa... Larynx Cancer Pharynx Cancer Hypopharynx Can... Hypopharynx Squ... | Zimberelimab Etrumadenant Cisplatin Radiation | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| GI Organ Tracking Via Balloon Applicators | NCT05471401 | Esophageal Canc... Kidney Cancer Larynx Cancer Liver Cancer Lung Cancer Digestive Organ... Intrathoracic--... Respiratory Org... Pancreas Cancer Small Intestine... Stomach Cancer Colon Cancer Rectal Cancer | Balloon-tipped ... | 18 Years - | Washington University School of Medicine | |
| Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis | NCT00661570 | Total Laryngect... | Provox Vega voi... | - | Atos Medical AB | |
| Cell-free Tumor DNA in Head and Neck Cancer Patients | NCT03942380 | Head and Neck C... Head and Neck N... Head and Neck S... Oropharynx Canc... Oropharynx Neop... Oropharynx Carc... Oral Cavity Can... Oral Cancer Oral Neoplasm Larynx Cancer Larynx Carcinom... Larynx Neoplasm Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Neo... Hypopharynx Can... Hypopharynx Neo... Hypopharynx Car... Sinonasal Carci... Thyroid Carcino... Thyroid Cancer Thyroid Neoplas... Salivary Gland ... Salivary Gland ... Salivary Gland ... Sinonasal Cance... Sinonasal Neopl... | Liquid biopsy | 18 Years - | Rigshospitalet, Denmark | |
| Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer | NCT01073683 | Larynx Cancer | laryngoscopy Taxotere (Docet... | 18 Years - | Rabin Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
